Molecular Genetics and Metabolism Reports

Scope & Guideline

Advancing the Frontiers of Molecular Genetics and Metabolism

Introduction

Delve into the academic richness of Molecular Genetics and Metabolism Reports with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN-
PublisherELSEVIER
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationMOL GENET METAB REP / Molec. Genet. Metab. Rep.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

Molecular Genetics and Metabolism Reports is dedicated to advancing the understanding of inherited metabolic disorders through the integration of molecular genetics and clinical findings. The journal aims to provide a platform for the dissemination of research that elucidates the genetic, biochemical, and clinical characteristics of various metabolic disorders, as well as their management and treatment options.
  1. Inherited Metabolic Disorders:
    The journal focuses on the study of inherited metabolic disorders, exploring their genetic underpinnings, clinical presentations, and biochemical pathways. This includes a wide range of conditions such as phenylketonuria, galactosemia, and various lysosomal storage disorders.
  2. Genetic Variants and Their Impact:
    A significant emphasis is placed on identifying and characterizing genetic variants associated with metabolic disorders. Research often includes case studies that detail novel mutations and their implications for patient management.
  3. Clinical Management and Treatment Outcomes:
    The journal publishes studies on the clinical management of metabolic disorders, including treatment efficacy, patient adherence, and long-term outcomes of therapies such as enzyme replacement therapy and dietary interventions.
  4. Innovative Diagnostic Approaches:
    There is a strong focus on new diagnostic methodologies, including whole-exome sequencing and biomarker discovery, aimed at improving the identification of metabolic disorders, particularly in newborn screening.
  5. Patient-Centered Research:
    The journal emphasizes research that considers the patient experience, including quality of life assessments, psychosocial impacts of metabolic disorders, and caregiver challenges.
The journal has seen a rise in several trending and emerging themes, indicating a shift in research focus and the evolving landscape of metabolic disorder studies.
  1. Genomic Approaches to Diagnosis:
    There is an increasing trend towards the use of genomic technologies, such as whole-exome sequencing and targeted gene panels, for the diagnosis of metabolic disorders. This shift allows for more precise identification of genetic variants and better understanding of disease mechanisms.
  2. Patient-Centric Studies and Quality of Life:
    Emerging research emphasizes patient-reported outcomes and quality of life assessments, reflecting a growing recognition of the importance of the patient experience in managing metabolic disorders.
  3. Innovative Therapeutic Strategies:
    Recent publications have highlighted novel therapeutic approaches, including gene therapy and substrate reduction therapies, indicating a shift towards more innovative treatment modalities for inherited metabolic disorders.
  4. Longitudinal Studies of Treatment Efficacy:
    There is a notable increase in longitudinal studies assessing the long-term efficacy and safety of treatments, particularly enzyme replacement therapies, which provide valuable insights into patient outcomes over time.
  5. Interdisciplinary Research Collaborations:
    The journal is increasingly featuring research that involves collaborations across various disciplines, combining insights from genetics, biochemistry, nutrition, and social sciences to address the complexities of metabolic disorders.

Declining or Waning

In recent years, certain themes within the 'Molecular Genetics and Metabolism Reports' have shown a decline in prominence. These waning scopes reflect changing research interests and advancements in the field.
  1. Traditional Enzyme Activity Assays:
    Research focusing on traditional enzyme activity assays as the primary diagnostic tool has decreased, with a shift towards more advanced genetic and molecular techniques such as next-generation sequencing.
  2. Single Case Reports of Rare Disorders:
    While the journal has historically published numerous single case reports for rare metabolic disorders, there seems to be a decline in the number of such publications, possibly due to a growing preference for larger cohort studies that provide more generalizable data.
  3. Basic Biochemical Studies:
    There is a noticeable reduction in purely biochemical studies that do not integrate genetic findings or clinical implications, as the field moves towards more multidimensional approaches that combine genetics, biochemistry, and clinical outcomes.

Similar Journals

Molecular Genetics & Genomic Medicine

Unlocking the secrets of molecular genetics.
Publisher: WILEYISSN: 2324-9269Frequency: 12 issues/year

Molecular Genetics & Genomic Medicine, published by WILEY, is an esteemed and open-access journal that has been a prominent source of knowledge in the fields of genetics and molecular biology since its establishment in 2013. With an ISSN of 2324-9269, it aims to provide a platform for the dissemination of novel findings and innovative research that pushes the boundaries of genomics and its clinical applications. The journal holds a Q3 categorization in Genetics, Clinical Genetics, and Molecular Biology, reflecting its growing influence in these disciplines, as evidenced by its Scopus rankings. Researchers, professionals, and students alike will find valuable insights and advancements in genomic medicine, making this journal an essential resource for those dedicated to the understanding and application of genetic and molecular research in healthcare. Located at 111 River St, Hoboken, NJ, Molecular Genetics & Genomic Medicine continues to foster a global dialogue within the scientific community, ensuring accessible knowledge for all.

CONGENITAL ANOMALIES

Pioneering research in pediatric health.
Publisher: WILEYISSN: 0914-3505Frequency: 4 issues/year

CONGENITAL ANOMALIES is a notable journal published by WILEY, dedicated to advancing the understanding of congenital disorders and anomalies through high-quality research and clinical insights. With an ISSN of 0914-3505 and an E-ISSN of 1741-4520, this journal has been a key resource for professionals in the fields of pediatrics, embryology, and developmental biology since its inception in 1973, although coverage discontinued in Scopus after 2019 due to evolving standards in publication. The journal is ranked in the 48th percentile in the domain of pediatrics, as well as in the 26th and 14th percentiles respectively for embryology and developmental biology, placing it among respected publications in its category. Although it does not currently offer open access options, its contributions remain vital for researchers, healthcare professionals, and students seeking up-to-date information on congenital anomalies, their origins, and potential interventions. With a commitment to fostering knowledge in this critical area of health science, CONGENITAL ANOMALIES continues to play an important role in the intersection of scientific research and clinical practice.

INTERNATIONAL JOURNAL OF HUMAN GENETICS

Illuminating Niche Topics in Genetic Research
Publisher: KAMLA-RAJ ENTERPRISESISSN: 0972-3757Frequency: 4 issues/year

INTERNATIONAL JOURNAL OF HUMAN GENETICS is a distinguished publication dedicated to advancing knowledge in the fields of genetics and molecular biology. Published by KAMLA-RAJ ENTERPRISES, this journal explores critical developments and research findings from 2008 to 2016, though its coverage in Scopus has since been discontinued. With an ISSN of 0972-3757 and an E-ISSN of 2456-6330, the journal aimed to foster scholarly dialogue and serve as a resource for researchers, professionals, and students engaged in human genetics. While the journal holds a modest ranking in categories such as Biochemistry and Genetics, it remains a vital source for exploring niche topics within the realm of human genetics. Researchers interested in genetic screening, gene therapy, and clinical genetics will find valuable insights herein. Despite its pause in indexing, the journal continues to contribute to the academic discourse by disseminating critical research that bridges gaps in understanding human genetics.

MOLECULAR GENETICS AND METABOLISM

Unraveling the Complexities of Molecular Interactions
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 1096-7192Frequency: 12 issues/year

MOLECULAR GENETICS AND METABOLISM, published by Academic Press Inc Elsevier Science, is a distinguished journal that has been at the forefront of advancing research since its inception in 1998. This journal, boasting both ISSN 1096-7192 and E-ISSN 1096-7206, focuses on the intricate interplay between molecular genetics and metabolic processes, making it an invaluable resource for researchers in the fields of biochemistry, endocrinology, and genetics. Recognized for its impact, it ranks in the Q1 and Q2 quartiles across multiple categories in the latest rankings, enhancing its reputation amongst scholars and professionals. With a commitment to disseminating cutting-edge research, it encourages innovative studies and comprehensive reviews that contribute to our understanding of gene function and metabolism. Open access options provide unrestricted access to its significant findings, further solidifying its role as a leading platform for scientific discourse. As it continues to thrive in the academic community, MOLECULAR GENETICS AND METABOLISM serves as a catalyst for novel insights and advancements in molecular biology.

Acta Endocrinologica-Bucharest

Nurturing emerging ideas in endocrinology and metabolism.
Publisher: EDITURA ACAD ROMANEISSN: 1841-0987Frequency: 4 issues/year

Acta Endocrinologica-Bucharest is a vital resource for those engaged in the study and practice of endocrinology, diabetes, and metabolic research. Published by EDITURA ACAD ROMANE, this journal emphasizes the dissemination of high-quality research and insights specific to the fields of endocrinology and autonomic systems. Although categorized in the lower quartiles of its subject areas according to the latest rankings—Q4 in Endocrine and Autonomic Systems and Q4 in Endocrinology—it serves as an important platform for emerging scientific ideas and collaborative studies within the endocrinology community. With an ISSN of 1841-0987 and an E-ISSN of 1843-066X, the journal provides a significant opportunity for authors to contribute to the growing body of knowledge in these fields from its base in Romania. Researchers and practitioners alike will find valuable contributions that reflect both contemporary challenges and advances in endocrinology, reinforcing the journal's commitment to enhancing scholarly communication.

LEUKEMIA RESEARCH

Exploring breakthroughs in hematology and oncology.
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0145-2126Frequency: 12 issues/year

Leukemia Research is a prominent academic journal dedicated to advancing the field of hematology and oncology, focusing on the latest research developments related to leukemia and other hematological disorders. Founded in 1977 and published by Pergamon-Elsevier Science Ltd in the United Kingdom, this esteemed journal has established itself as a vital resource for researchers and clinicians alike. With an impressive impact factor and categorized in the top quartiles of Cancer Research and Hematology, it provides a platform for high-quality research articles, reviews, and clinical studies that contribute to a deeper understanding of leukemia's complexities. Although not an Open Access journal, Leukemia Research ensures widespread dissemination of knowledge crucial for developing innovative treatment strategies and improving patient outcomes. Researchers, professionals, and students in the fields of hematology and oncology will find this journal an invaluable asset in staying at the forefront of leukemia research, as it prepares to expand its impact through converged years of publication extending into 2024.

Clinical Pediatric Endocrinology

Illuminating the path to better health for children with metabolic disorders.
Publisher: JAPANESE SOC PEDIATRIC ENDOCRINOLOGYISSN: 0918-5739Frequency: 4 issues/year

Clinical Pediatric Endocrinology is a prestigious journal dedicated to advancing the field of pediatric endocrinology, published by the Japanese Society of Pediatric Endocrinology. With a respectable ISSN 0918-5739 and E-ISSN 1347-7358, this journal serves as a critical platform for innovative research spanning various aspects of endocrine disorders in children, including diabetes and metabolic conditions. Although it does not currently offer open access, it remains highly relevant in its category, being ranked in Q4 and Q3 tiers across multiple specialties as of 2023. With a publication history that spans from 1992 to 2024, this journal has contributed significantly to the literature, as evidenced by its inclusion in prominent databases. It invites submissions from researchers and practitioners worldwide, aiming to facilitate knowledge sharing and improve clinical practices in pediatric endocrinology. For those dedicated to enhancing care outcomes in children with endocrine disorders, Clinical Pediatric Endocrinology provides essential insights and fosters a community of engaged professionals.

HAEMOPHILIA

Fostering collaboration for groundbreaking discoveries.
Publisher: WILEYISSN: 1351-8216Frequency: 6 issues/year

HAEMOPHILIA is a leading peer-reviewed journal published by Wiley, dedicated to advancing research and clinical practices in the fields of hematology and genetics. With an impressive Impact Factor and recognition within the Q1 category for Genetics (clinical), Hematology, and Medicine (miscellaneous), this journal presents a unique platform for the dissemination of high-quality research from 1995 to the present. Researchers in these dynamic fields will find invaluable insights through original articles, systematic reviews, and clinical trials, all aimed at improving therapeutic strategies and patient outcomes. Although it operates on a subscription basis, HAEMOPHILIA's commitment to excellence is reflected in its Scopus rankings, where it stands in the 74th percentile for hematology and the 71st percentile for clinical genetics. As an essential resource for academics, healthcare professionals, and students, HAEMOPHILIA plays a pivotal role in fostering innovation and collaboration within the global medical community.

JOURNAL OF MEDICAL GENETICS

Transforming Genetic Discoveries into Clinical Applications.
Publisher: BMJ PUBLISHING GROUPISSN: 0022-2593Frequency: 12 issues/year

JOURNAL OF MEDICAL GENETICS, published by the BMJ PUBLISHING GROUP, stands as a premier platform in the field of genetics, focusing on both fundamental genetic research and its clinical applications. With a distinctive legacy dating back to 1965 and a significant role in advancing the understanding of genetic disorders, this journal has established itself in the top tiers with a commendable Q1 category ranking in both Genetics and Clinical Genetics as of 2023. The journal's impact is underscored by its Scopus rankings, placing it among the leading journals in the fields of medicine and genetics. Researchers and practitioners are drawn to its rigorous peer-review process and its commitment to disseminating high-quality research findings, critical reviews, and innovative clinical practices. While it is not an open-access journal, the insights provided are invaluable for anyone looking to deepen their knowledge or contribute to the burgeoning field of medical genetics.

NEUROMUSCULAR DISORDERS

Transforming understanding through impactful findings.
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0960-8966Frequency: 12 issues/year

NEUROMUSCULAR DISORDERS is a premier academic journal published by PERGAMON-ELSEVIER SCIENCE LTD, focusing on the latest research and developments in the fields of neurology, genetics, and pediatric health. With an ISSN of 0960-8966 and an E-ISSN of 1873-2364, this journal has established a significant presence since its inception in 1991, and it continues to contribute to the scientific community with its impactful findings and reviews. The journal boasts a commendable impact factor, reflected in its placement in the Q2 category for Clinical Genetics and Neurology, as well as its positioning in the top tier Q1 for Pediatrics, Perinatology and Child Health according to the latest quartile assessments. With Scopus rankings such as Rank #71/330 in Pediatrics and Rank #51/99 in Clinical Genetics, NEUROMUSCULAR DISORDERS is recognized for its contribution to advancing knowledge in neuromuscular diseases. The journal is essential for researchers, clinicians, and students interested in the intricate relationship between genetics and neurological disorders, providing valuable insights that drive innovation and improve patient care.